The transcription factor CREBZF is a novel positive regulator of p53

Cell Cycle

Volumn 11, Issue 20, 2012, Pages 3887-3895

  López Mateo, Irene ^a   Villaronga, M Ángeles ^b   Llanos, Susana ^c   Belandia, Borja ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

5 fluorouracil; CREBZF; DNA damage; HEY1; P53; Ultraviolet radiation

Indexed keywords

EID: 84868028198     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.22133     Document Type: Article

References (35)

1. Dotto G P. Crosstalk of Notch with p53 and p63 in cancer growth control. Nat Rev Cancer 2009;9:587-95; PMID:19609265; http://dx.doi.org/10.1038/nrc2675.
2. Huang Q, Raya A, DeJesus P, Chao SH, Quon KC, Caldwell JS, et al. Identification of p53 regulators by genome-wide functional analysis. Proc Natl Acad Sci USA 2004;101:3456-61; PMID:14990790; http://dx.doi.org/10.1073/pnas. 0308562100. (Pubitemid 38338216)
3. Villaronga MA, Lavery DN, Bevan CL, Llanos S, Belandia B. HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions. Oncogene 2010;29:411-20; PMID:19802006; http://dx.doi.org/10.1038/onc.2009.309.
4. Ban J, Bennani-Baiti IM, Kauer M, Schaefer KL, Poremba C, Jug G, et al. EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma. Cancer Res 2008;68:7100-9; PMID:18757425; http://dx.doi.org/10.1158/0008-5472. CAN-07-6145.
5. DeMarzo AM, Nelson WG, Isaacs WB, Epstein JI. Pathological and molecular aspects of prostate cancer. Lancet 2003;361:955-64; PMID:12648986; http://dx.doi.org/10.1016/S0140-6736 (03) 12779-1. (Pubitemid 36332115)
6. Rodriguez V, Chen Y, Elkahloun A, Dutra A, Pak E, Chandrasekharappa S. Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer. Genes Chromosomes Cancer 2007;46:694-707; PMID:17440925; http://dx.doi.org/10.1002/ gcc.20454. (Pubitemid 46802337)
7. Augenlicht LH, Wadler S, Corner G, Richards C, Ryan L, Multani AS, et al. Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial. Cancer Res 1997;57:1769-75; PMID:9135021. (Pubitemid 27199672)
8. Stock C, Kager L, Fink FM, Gadner H, Ambros P F. Chromosomal regions involved in the pathogen-esis of osteosarcomas. Genes Chromosomes Cancer 2000;28:329-36; PMID:10862039; http://dx.doi.org/10.1002/1098-2264 (200007) 28:3<329::AID-GCC11>3.0. CO;2-F. (Pubitemid 30399563)
9. Loukopoulos P, Shibata T, Katoh H, Kokubu A, Sakamoto M, Yamazaki K, et al. Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome. Cancer Sci 2007;98:392-400; PMID:17233815; http://dx.doi.org/ 10.1111/j.1349-7006.2007.00395.x. (Pubitemid 46195611)
10. Belandia B, Powell SM, García-Pedrero JM, Walker MM, Bevan CL, Parker MG. Hey1, a mediator of notch signaling, is an androgen receptor corepressor. Mol Cell Biol 2005;25:1425-36; PMID:15684393; http://dx.doi.org/10. 1128/MCB.25.4.1425-1436.2005. (Pubitemid 40204919)
11. Xie YB, Lee OH, Nedumaran B, Seong HA, Lee KM, Ha H, et al. SMILE, a new orphan nuclear receptor SHP-interacting protein, regulates SHP-repressed estrogen receptor transactivation. Biochem J 2008;416:463-73; PMID:18657049; http://dx.doi.org/10.1042/BJ20080782.
12. Contente A, Dittmer A, Koch MC, Roth J, Dobbelstein M. A polymorphic microsatellite that mediates induction of PIG3 by p53. Nat Genet 2002;30:315-20; PMID:11919562; http://dx.doi.org/10.1038/ng836.
13. Lu R, Misra V. Zhangfei: a second cellular protein interacts with herpes simplex virus accessory factor HCF in a manner similar to Luman and VP16. Nucleic Acids Res 2000;28:2446-54; PMID:10871379; http://dx.doi.org/10.1093/nar/ 28.12.2446. (Pubitemid 30349052)
14. Kruse J P, Gu W. Modes of p53 regulation. Cell 2009;137:609-22; PMID:19450511; http://dx.doi.org/10.1016/j.cell.2009.04.050.
15. Kim SB, Chae GW, Lee J, Park J, Tak H, Chung JH, et al. Activated Notch1 interacts with p53 to inhibit its phosphorylation and transactivation. Cell Death Differ 2007;14:982-91; PMID:17186020. (Pubitemid 46629836)
16. Longley DB, Harkin D P, Johnston PG. 5-fluoroura-cil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003;3:330-8; PMID:12724731; http://dx.doi.org/10.1038/nrc1074. (Pubitemid 37328853)
17. Lu C, El-Deiry WS. Targeting p53 for enhanced radio-and chemo-sensitivity. Apoptosis 2009;14:597-606; PMID:19259822; http://dx.doi.org/10.1007/s10495-009-0330-1.
18. Ooyama A, Okayama Y, Takechi T, Sugimoto Y, Oka T, Fukushima M. Genome-wide screening of loci associated with drug resistance to 5-fluorouracil-based drugs. Cancer Sci 2007;98:577-83; PMID:17425594; http://dx.doi.org/10.1111/j.1349-7006.2007.00424.x. (Pubitemid 46562750)
19. Hai T, Hartman MG. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 2001;273:1-11; PMID:11483355; http://dx.doi.org/10.1016/S0378-1119 (01) 00551-0. (Pubitemid 32718721)
20. Hogan MR, Cockram G P, Lu R. Cooperative interaction of Zhangfei and ATF4 in transactivation of the cyclic AMP response element. FEBS Lett 2006;580:58-62; PMID:16343488; http://dx.doi.org/10.1016/j.febslet.2005.11.046. (Pubitemid 43005312)
21. Xie YB, Nedumaran B, Choi HS. Molecular characterization of SMILE as a novel corepressor of nuclear receptors. Nucleic Acids Res 2009;37:4100-15; PMID:19429690; http://dx.doi.org/10.1093/nar/gkp333.
22. Bergeron T, Zhang R, Elliot K, Rapin N, Macdonald V, Linn K, et al. The effect of Zhangfei on the unfolded protein response and growth of cells derived from canine and human osteosarcomas. Vet Comp Oncol 2012; PMID:22243984; http://dx.doi.org/10.1111/j.1476-5829.2011.00310.x.
23. Misra J, Chanda D, Kim DK, Li T, Koo SH, Back SH, et al. Curcumin differentially regulates endoplasmic reticulum stress through transcriptional corepressor SMILE (small heterodimer partner-interacting leucine zipper protein)-mediated inhibition of CREBH (cAMP responsive element-binding protein H). J Biol Chem 2011;286:41972-84; PMID:21994947; http://dx.doi.org/10.1074/jbc. M111.274514.
24. Zhang Y, Jin Y, Williams TA, Burtenshaw SM, Martyn AC, Lu R. Amino acid deprivation induces CREBZF/Zhangfei expression via an AARE-like element in the promoter. Biochem Biophys Res Commun 2010;391:1352-7; PMID:20026304; http://dx.doi.org/10.1016/j.bbrc.2009.12.059.
25. Yang F, Stenoien DL, Strittmatter E F, Wang J, Ding L, Lipton MS, et al. Phosphoproteome profiling of human skin fibroblast cells in response to low-and high-dose irradiation. J Proteome Res 2006;5:1252-60; PMID:16674116; http://dx.doi.org/10.1021/pr060028v. (Pubitemid 43727805)
26. Yan C, Lu D, Hai T, Boyd DD. Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J 2005;24:2425-35; PMID:15933712; http://dx.doi.org/10.1038/sj.emboj.7600712. (Pubitemid 41032593)
27. Sun XX, Dai MS, Lu H. 5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction. J Biol Chem 2007;282:8052-9; PMID:17242401; http://dx.doi.org/10.1074/jbc. M610621200. (Pubitemid 47093604)
28. Jönsson G, Dahl C, Staaf J, Sandberg T, Bendahl PO, Ringnér M, et al. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH. Oncogene 2007;26:4738-48; PMID:17260012; http://dx.doi.org/10.1038/sj. onc.1210252. (Pubitemid 47067402)
29. Maris JM, Guo C, White PS, Hogarty MD, Thompson PM, Stram DO, et al. Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma. Med Pediatr Oncol 2001;36:24-7; PMID:11464895; http://dx.doi.org/10.1002/1096-911X (20010101) 36:1<24::AID-MPO1007>3.0. CO;2-7. (Pubitemid 32052990)
30. Smeets SJ, Braakhuis BJ, Abbas S, Snijders PJ, Ylstra B, van de Wiel MA, et al. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene 2006;25:2558-64; PMID:16314836; http://dx.doi.org/10.1038/sj.onc.1209275.
31. Karhu R, Knuutila S, Kallioniemi O P, Siltonen S, Aine R, Vilpo L, et al.; Tampere CLL Group. Frequent loss of the 11q14-24 region in chronic lymphocytic leukemia: a study by comparative genomic hybridization. Genes Chromosomes Cancer 1997;19:286-90; PMID:9258665; http://dx.doi.org/10.1002/ (SICI) 1098-2264 (199708) 19:4<286::AID-GCC12>3.0. CO;2-E. (Pubitemid 27330241)
32. Swarts DR, Claessen SM, Jonkers YM, van Suylen RJ, Dingemans AM, de Herder WW, et al. Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome. Am J Pathol 2011;179:1129-37; PMID:21763262; http://dx.doi.org/10.1016/j.ajpath.2011.05.028.
33. Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, Thibodeau SN, et al. Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet 2006;120:471-85; PMID:16932970; http://dx.doi.org/10.1007/s00439-006-0219-9. (Pubitemid 44669782)
34. Rain JC, Selig L, De Reuse H, Battaglia V, Reverdy C, Simon S, et al. The protein-protein interaction map of Helicobacter pylori. Nature 2001;409:211-5; PMID:11196647; http://dx.doi.org/10.1038/35051615. (Pubitemid 32144288)
35. Belandia B, Orford RL, Hurst HC, Parker MG. Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes. EMBO J 2002;21:4094-103; PMID:12145209; http://dx.doi.org/10.1093/emboj/cdf412. (Pubitemid 34857441)